H E Reis, U Bruntsch, C G Schmidt. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AdolescentAdultAge FactorsAutoimmune Diseases/complicationsChemical PhenomenaChemistryCytarabine/administration & dosageCytarabine/metabolismCytarabine/therapeutic useDrug EvaluationDrug Therapy, CombinationFemaleHerpes Labialis/complicationsHerpes Labialis/drug therapyHerpes Zoster/complicationsHerpes Zoster/drug therapyHerpes Zoster Ophthalmicus/drug therapyHodgkin Disease/complicationsHumansImmunosuppressive Agents/therapeutic useInjections, IntravenousLymphoma, Large B-Cell, Diffuse/complicationsMaleMiddle Aged
Substances： See more » Immunosuppressive AgentsCytarabine
Year: 1973 PMID： 4587114 DOI： 10.1055/s-0028-1107243
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN： 0012-0472 Impact factor: 0.628